Abbvie Inc (ABBV) |
|
84.34 0.03 (0.04%)
|
10-24 22:34 |
|
Open: |
84.64 |
Pre. Close: |
84.31 |
|
High:
|
85.15 |
Low:
|
83.94 |
|
Volume:
|
4,143,056 |
Market Cap:
|
148,846M |
|
|
|
|
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Illinois and currently employs 30,000 full-time employees. The firm is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. Its products are focused on treating conditions, such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease and multiple sclerosis; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis, and other serious health conditions. The company offers products in various categories, including HUMIRA (adalimumab), Oncology products, Virology Products, Additional Virology products, Metabolics/Hormones products, Endocrinology products and other products, which include Duopa and Duodopa (carbidopa and levodopa), Anesthesia products and ZINBRYTA (daclizumab). |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
85.295 - 85.702 |
85.702 - 86.072 |
|
Low:
|
82.918 - 83.401 |
83.401 - 83.839 |
|
Close:
|
83.556 - 84.338 |
84.338 - 85.048 |
|
Technical analysis |
as of: 2020-10-23 4:40:08 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 101.39  One year: 104.45 |
| Support: |
Support1: 82.56 Support2: 68.69 |
| Resistance: |
Resistance1: 86.81 Resistance2: 89.43 |
| Pivot: |
85.98 |
| Moving Average: |
MA(5): 84.02 MA(20): 86.24
MA(100): 93.03 MA(250): 88.51  |
| MACD: |
MACD(12,26): -1.50 Signal(9): -1.41 |
| Stochastic oscillator: |
%K(14,3): 20.62 %D(3): 15.02 |
| RSI: |
RSI(14): 39.43 |
| 52-week: |
High: 101.28 Low: 62.55 Change(%): 7.7 |
| Average Vol(K): |
3-Month: 725440 10-Days: 717940 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.ABBV has closed above bottom band by 24.9%. Bollinger Bands are 8.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Fri, 23 Oct 2020
AbbVie (ABBV) Reports Next Week: Wall Street Expects Earnings Growth - Nasdaq
Wed, 21 Oct 2020
Are You Looking for a High-Growth Dividend Stock? AbbVie (ABBV) Could Be a Great Choice - Yahoo Finance
Tue, 20 Oct 2020
AbbVie: Stock Will Break $100 Once Management And Market Are On Same Page - Seeking Alpha
Tue, 20 Oct 2020
Were Hedge Funds Right About Crowding AbbVie Inc (ABBV)? - Yahoo Finance
Fri, 16 Oct 2020
AbbVie Inc. [ABBV] fell -3.74% so far this year. What now? - The DBT News
Tue, 13 Oct 2020
What do the Fundamentals Predict for AbbVie Inc (ABBV) Stock? - InvestorsObserver
|
Financial Analysis |
| Growth |
|
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Neutral |
Price to Earnings: |
Underperform |
| Return on Equity: |
Neutral |
Debt to Equity: |
Outperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NYSE |
| Sector: Healthcare |
| Industry: Drug Manufacturers General |
| Shares Out. (M) |
1,760 |
| Shares Float (M) |
1,760 |
|
% Held by Insiders
|
0.11 |
|
% Held by Institutions
|
76.76 |
|
Shares Short (K)
|
13,280 |
|
Shares Short P. Month (K)
|
12,410 |
Stock Financials |
|
EPS
|
4.520 |
|
EPS Est This Year
|
5.530 |
|
EPS Est Next Year
|
6.560 |
|
Book Value (p.s.)
|
8.340 |
|
Profit Margin
|
19.20 |
|
Operating Margin
|
37.55 |
|
Return on Assets (ttm)
|
8.2 |
|
Return on Equity (ttm)
|
225.6 |
|
Qtrly Rev. Growth
|
26.3 |
|
Gross Profit (p.s.)
|
14.676 |
|
Sales Per Share
|
20.585 |
|
EBITDA (p.s.)
|
9.506 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
14,730 |
|
Levered Free Cash Flow (M)
|
13,020 |
Stock Valuations |
|
PE Ratio
|
18.66 |
|
PEG Ratio
|
1.28 |
|
Price to Book value
|
10.11 |
|
Price to Sales
|
4.10 |
|
Price to Cash Flow
|
10.08 |
Stock Dividends |
|
Dividend
|
4.610 |
|
Forward Dividend
|
4.720 |
|
Dividend Yield
|
0.05 |
|
Dividend Pay Date
|
2020-11-15 |
|
Ex-Dividend Date
|
2020-10-13 |
|
7 Binary Options
|
|
Your Ad Here
|
|
